Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Carolina Villegas et al.|European Journal Of Haematology|2020Cited by 96
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid‐19 patientsMario Rodríguez, Joaquín Martínez‐López, Nerea Castro Quismondo et al.|International Journal of Laboratory Hematology|2021Cited by 30
Thrombosis and antiphospholipid antibodies in patients with SARS‐COV‐2 infection (COVID‐19)Xabier Gutiérrez López de Ocáriz, Joaquín Martínez‐López, Nerea Castro Quismondo et al.|International Journal of Laboratory Hematology|2020Cited by 25
Clinical Course and Risk Factors for Mortality from COVID-19 in Patients with Hematological MalignanciesJosé María Sánchez‐Pina, María Calbacho, Mario Rodríguez et al.|SSRN Electronic Journal|2020Cited by 1